Dr. Vikas Asati

DM, MD Medical Oncology and Consultant  

Professional Summary  

Dr.Vikas Asati has completed his Bachelors of Medicine and Bachelors of Surgery (MBBS) in year 2011 and MD in General Medicine from Mahatma Gandhi Medical College, Indore in year 2014. He then completed his Doctorate of Medicine (DM) in Medical Oncology from Kidwai Cancer Institute, Bengaluru in year 2018. 

Technical Skills  

  1. Treatment and counselling of patients receiving systemic therapies for solid and haematological malignancies: Chemotherapy, Hormonal therapies, biological therapies, Targeted Therapy, Immunotherapy.  
  2. Prescribe and administer Chemotherapy, biological therapy, Immunotherapy, Targeted therapy.  
  3. Diagnose and manage side effects of anti-cancer treatments.  
  4. Perform central line insertion, PICC line insertion, Bone Marrow aspiration and biopsy, lumbar puncture and intrathecal drug administration.  
  5. Perform image-guided tru-cut biopsies, FNAC’s, pleural and peritoneal paracentesis.  
  6. Diagnose and manage medical and oncological emergencies.
  7. Autologous stem-cell transplant for Hodgkin’s lymphoma, Non-Hodgkin’s lymphoma, Multiple Myeloma. 
  8. Induction and consolidation chemotherapies for ALL/AML.  
  9. Management of malignancies in patients with HIV/AIDS.  
  10. Participate and contribute in a Multidisciplinary clinic. 

Scientific And Medical Societies Membership

A. European Society of Medical Oncology (ID-531280)

B.American Society of Clinical Oncology (ID-6908307)

C. Indian Society of Medical and Pediatric Oncology (ID-1332) 

Awards and Achievements 

Work Experience 

  1. Junior Residency (During MD training, General medicine, at MGM Medical College, Indore, May, 2011-May, 2014)

a. Significant experience in diagnosing illnesses, prescribing and administering appropriate treatment/medications for various ailments or diseases.

b. Experience in handling in/out Patients and managing ICU, ICCU & monitoring the patients. 

c.Proficiency in patient counselling and training subordinates in protocol-based management of cases.

d.Teaching experience to undergraduate (MBBS) students.  

2. Senior Residency in Department of Medicine at ESI Model Hospital, Indore ( July 2014- August 2015) 

a. Management of patients admitted in intensive care unit under the department of medicine.  

3. DM training (Medical Oncology) at Kidwai Cancer Institute (earlier known as Kidwai Memorial Institute of Oncology), Bengaluru, August 2015- August 2018). 

a. Out-patient and in-patient care of cancer patients.

b. Workup and management of patients with various solid tumors. 

c. Workup and management of leukemia and lymphoma patients. 

d. Prescribing and supervising chemotherapy administration.

e. Providing Expert consultation to other Departments.

f. Teaching experience

i. Nursing: Chemotherapy preparation and administration. 

ii. Medicine Graduates: Principles of oncology, oncological emergencies, Approach to a patient with generalized lymphadenopathy, Management of hematological malignancies.

Conferences and Seminars 

A. Intradepartmental (Department of medical oncology) 

a) Hallmarks of cancer

b) Pharmacology, clinical use and adverse effect of antitumor antibiotics (including anthracyclines)

c) Screening of Cervical cancer, Prostate cancer

d) Recent advances in screening of lung cancer 

e) Role of myeloid growth factor in oncology

f) Management of Diffuse large B-cell lymphoma

g) Management of Mantle cell lymphoma  

B. Interdepartmental (Multidisciplinary meeting)

a) Role of chemotherapy and targeted therapy in carcinoma stomach  

Projects

i. Clinical Characteristics, Management Practices, and Outcome in Patients with Cerebrovascular Accident at Maharaja Yashwant Hospital Indore, a tertiary care centre in central India. (Dissertation during M.D.). 

ii. A Prospective Study to Determine the Clinical Characteristics and Response to Treatment in Double Expressor DLBCL Among All DLBCL Patients in a Tertiary Care Hospital in South India, Kidwai Cancer Institute. (Dissertation during D.M.).

iii. Role of prephase treatment prior to definitive chemotherapy in patients with diffuse large B-cell lymphoma. (Project)

iv. Assessment and comparison of CISNE model versus MASCC model in clinically stable febrile neutropenia patients. Kidwai Cancer Institute. (Project)

v. CXCR-4 expression and its correlation with Clinical- Biological characteristics in patients with Acute Myeloid Leukemia. Kidwai Cancer Institute. (Project).

vi. A Prospective study to evaluate Pathological, Radiological response, Toxicity profile, and Pharmacoeconomics of IAP and AP Regimens in localized high – grade osteosarcoma as Neoadjuvant chemotherapy (Project). 

Publications

A. Original Articles

  1. Triggering PIK3CA mutations in PI3K/AKT/mTOR axis: Exploration of newer inhibitors and rational preventive strategies. Vivek Asati, Sanjay K. Bharti, Debarshi Kar Mahapatra, Vikas Asati, Ashok K. Budhwani, Journal Name: Current Pharmaceutical Design, Volume 22, Issue 39, 2016. DOI: 10.2174/1381612822666160614000053
  2. Role of prephase treatment prior to definitive chemotherapy in patients with diffuse large B‐cell lymphoma. Lakshmaiah, K. C., Asati, V. , Babu, K. G., Lokanath, D. , Jacob, L. A., Babu, M. C., Lokesh, K. N., Rajeev, L. K., Rudresh, A. H., Saldanha, S., Koppaka, D. , Patidar, R. and Premalata, C. S. (2018 Eur J Haematol. DOI: 10.1111/ejh.13068 (Corresponding author: Asati Vikas) 
  3. Primary cutaneous B-cell lymphoma: A single-center 5-year experience. Jacob LA, Asati Vikas, Lakshmaiah KC, Govind B, Lokanatha D, Babu S, Lokesh KN, Rudresh AH, Rajeev LK, Mulchandani JN, Anand A, Koppaka D, Suma MN. Indian J Cancer 2017;XX:XX-XX. DOI: 10.4103/ijc.IJC_418_17. (Corresponding author: Asati Vikas) 
  4. Every distant deposit not a metastasis: Synchronous primaries do exist. Babu G, Asati Vikas, Lakshmaiah KC, Lokanatha D, Jacob LA, Babu S, Babu S, Lokesh KN, Rudresh AH, Rajeev LK Smitha S, Chethan R, Koppaka D, Premalata C. S. Indian J Cancer, 2018. XX:XX-XX DOI:10.4103/ijc.IJC_637_17. (Corresponding author: Asati Vikas) 
  5. A prospective study to compare the measured glomerular filtration rate compared to estimated glomerular filtration rate in patients undergoing definitive chemoradiation, with platinum agents for various malignancies. Rudresh A, Asati V, Lakshmaiah K, Lokanatha D, Babu S, Rajeev L, et al J Can Res Ther 0;0:0. DOI: 10.4103/0973-1482.204881. (Corresponding author: Asati Vikas) 
  6. Pattern of bone marrow involvement by solid tumors: Experience from a tertiary care center from South India. AH Rudresha, Rajesh Patidar, Kuntegowdanahalli C Lakshmaiah, K Govind Babu, Dasappa Lokanatha, Linu Abraham Jacob, MC Suresh Babu, NR Namrata, N Lokesh Kadabur, LK Rajeev, Abhishek Anand, Vikas Asati. Indian J Med Paediatr Oncol 2018;XX:XX-XX. DOI: 10.4103/ijmpo.ijmpo_170_17 
  7. Metastatic Synovial Sarcoma: Experience from a Tertiary Care Center from India. K Govind Babu, Rajesh Patidar, C Lakshmaiah Kuntegowdanahalli, Lokanatha Dasappa, Linu Abraham Jacob, Suresh Babu, AH Rudresha, Lokesh N Kadabur, LK Rajeev, Deepak Koppaka, Vikas Asati. DOI: 

    10.4103/ijmpo.ijmpo_237_17 

  8. Primary gastrointestinal diffuse large Bcell lymphoma: A prospective study from South India. Babu Suresh, Vikas Asati, K. C. Lakshmaiah, Govind Babu, D. Lokanatha, Linu Abraham Jacob, K. N. Lokesh, A. H. Rudresh, L. K. Rajeev, Saldanha Smitha, Abhishek Anand, Rajesh Patidar, C. S. Premalatha. DOI: 10.4103/sajc.sajc_52_18 (Corresponding author: Asati Vikas) 
  9. Pro-oncogenic, intra host viral quasispecies in Diffuse large B cell lymphoma patients with occult Hepatitis B Virus infection. Mahua Sinha, Keerthana Sundar, C. S. Premalata, Vikas Asati et al. Pro-oncogenic, intra host viral quasispecies in Diffuse large B cell lymphoma patients with occult Hepatitis B Virus infection. Sci Rep 9, 14516 (2019). https://doi.org/10.1038/s41598-019-51157-1
  10. Detection of clinically relevant epidermal growth factor receptor pathway mutations in circulating cellfree tumor DNA using next generation sequencing in squamous cell carcinoma lung. Kanakasetty Babu Govind, Deepak Koppaka, Lokanatha Dasappa, Linu Abraham Jacob, Suresh M. C. Babu, N. Kadabur Lokesh, Rudresha Antapura Haleshappa, L. K. Rajeev, Smitha Carol Saldanha, Anand Abhishek, Vikas Asati, R. Chethan, Vedam Laxmi Ramprasad. South Asian J Cancer 2019;8:247-9. DOI: 10.4103/sajc.sajc_281_18 
  11. Treatment patterns and comparativeanalysis of non-intensive regimens inelderly acute myeloid leukemia patients—areal-world experience from India. Govind B. Kanakasetty, Chethan R Lakshmaiah K C, Lokanatha Dasappa, Linu Abraham Jacob, Suresh Babu M C, Lokesh K N, Rudresha Antapura Haleshappa, Rajeev L K, Smitha Carol Saldanha, Koppaka Deepak, Patidar Rajesh, Vikas Asati. Ann Hematol 98, 881–888 (2019). https://doi.org/10.1007/s00277-019-03600-6  

B. Abstract 

  1. Role of prephase treatment prior to definitive chemotherapy in diffuse large B-cell lymphoma (DLBCL) A. Rudresha, V. Asati, L.C. Kuntegowdanahalli, G. Babu, D. Lokanatha, L.A. Jacob, S. Babu, C.S. Premalata, L. Rajeev, K.N. Lokesh, S.C. Saldanha, R. Patidar; 1012P. Annals of Oncology, Volume 28, Issue suppl_5, 1 September 2017, mdx373.018. 
  2. CXCR-4 EXPRESSION AND ITS PROGNOSTIC IMPACT IN DE NOVO ACUTE MYELOID LEUKEMIA PATIENTS- SINGLE INSTITUTION EXPERIENCE FROM SOUTH INDIA. Rajegowda, C, BABU G, C, L. K1; ABRAHAM JACOB, Koppaka, D.; Asati, Vikas, Patidar, R HemaSphere: June 2019 – Volume 3 – Issue S1 – p 785 doi:10.1097/01.HS9.0000565332.28450
  3. Efficacy and safety of modified ECF regimen as first-line chemotherapyin metastatic gastric adenocarcinoma: A phase II study. T. Chaudhuri, K.G. Babu, K.C. Lakshmaiah, L. Dasappa, L.A. Jacob, M.C.S. Babu,K.N. Lokesh, A.H. Rudresha, L.K. Rajeev, R. Patidar, V. Asati, R. Chethan, D. Koppaka, A. Anand. Annals of Oncology 29(suppl_9) DOI: 10.1093/annonc/mdy432.013 
  4. Capacity building in stem cell transplantation for children and young adults with transplant-treatable diseases in rural Madhya Pradesh, India: social entrepreneurship meets academia. B S Ankit, Ankur Punia, Yadlapalli C. Deepak, Runu Sharma, Anjali Chitalkar, Chandan S. Rajput, Vikas Asati, Rajesh Patidar, Prakash Chitalkar; Capacity building in stem cell transplantation for children and young adults with transplant-treatable diseases in rural Madhya Pradesh, India: social entrepreneurship meets academia. Blood Adv 2019; 3 (Supplement1):38–40.doi: 2019GS121755  

C. Review Article

  1. Cancer of unknown primary: Opportunities and challenges. Rajeev L K, Asati V, Lokesh K N, Rudresh A H, Babu S, Jacob LA, Lokanatha D, Babu G, Lakshmaiah K C Indian J Med Paediatr Oncol 2018;39:219-26. DOI: 10.4103/ijmpo.ijmpo_91_17 (Corresponding author: Asati V) 

D. Case Report 

  1. Synchronous primary cancers: Renal cell carcinoma and rectal cancer. Babu MC, Asati V, Babu KG, Suma MN, Rajeev LK, Lokesh KN. J Can Res Ther 2018;XX:XX-XX. DOI: 10.4103/jcrt. JCRT_45_17. (Corresponding author: Asati Vikas)
  2.  Epithelioid Sarcoma Presenting as Recurrent Thumb Ulcer: a Lesson to Learn. L. K. Rajeev, Vikas Asati, Suresh Babu, Govind Babu, G. Champaka. Indian journal of surgical oncology. DOI: https://doi.org/10.1007/s13193-018-0727-9 (Corresponding author: Asati Vikas) 

 

 

TESTIMONIAL